-
experience or knowledge within virology and vaccine development fields. Virus infections of cell cultures will be a routine procedure, and occasional assistance in injections of attenuated poxviruses in tumor
-
technology, research, and clinical cellular immunotherapy programs, including cell viability, Flow Cytometry, ELISA, qPCR, ddPCR, potency, and cytotoxicity assays. The QCA II will also receive training
-
and collaboration across disciplines, for example cross-talk between diabetes immunologists, cancer immunologists, and beta cell biologists. City of Hope is also home to the Wanek Family Project
-
will: Ability to carry out cell culture experiments using transfection agents and RNA isolation to perform RT PCR experiments. Willingness to learn animal handling and testing with humanized mouse models
-
) to support GMP Manufacturing and analytical development for cellular immunotherapy products. This role involves performing QC assays, release tests, and assay development tasks, including cell viability, Flow
-
immunotherapeutic programs, including cell viability, Flow Cytometry, ELISA, qPCR, ddPCR, potency, and cytotoxicity assays. The QCA III will be trained on assay qualification and project-specific techniques
-
, including cell viability, Flow Cytometry Assays, ELISA, RT-PCR, and cytotoxicity assays. The QCA III will receive training in assay qualification and project-specific techniques to support various QC
-
trial to determine the safety and efficacy of islet cell transplantation as a treatment for patients with type 1 diabetes. In addition, Dr. Kandeel has recently concluded a clinical project to identify